FDA Approves Pfizer's NGENLA™, Weekly Treatment for Pediatric Growth Hormone Deficiency

Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon...

June 29, 2023 | Thursday | News
Thermo Fisher Scientific Launches Cancer Treatment-Enabling Tumor Culture Medium

Thermo Fisher Scientific, a global leading company in science services, today announced the launch of the Gibco™ OncoPro™ tumor media kit. *, t...

June 29, 2023 | Thursday | News
Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

Gadoquatrane is a highly stable contrast agent for magnetic resonance imaging (MRI) with high relaxivity and the potential of a substantially lower gadol...

June 28, 2023 | Wednesday | News
Theriva Biologics Receives FDA Orphan Drug Designation for VCN-01 in Pancreatic Cancer Treatment

In VIRAGE, the ongoing multinational Phase 2b clinical study, intravenous VCN-01 is being evaluated in combination with standard-of-care (SoC) chemotherapy...

June 28, 2023 | Wednesday | News
Genmab and AbbVie Report Positive Results from EPCORE™ NHL-1 Trial for Epcoritamab in Relapsed/Refractory Follicular Lymphoma

Based on the topline results from the EPCORE™ NHL-1 clinical trial, Genmab and AbbVie will engage with global regulatory authorities to discuss nex...

June 28, 2023 | Wednesday | News
Antibody-Drug Conjugates Clinical Trial Pipeline Gains Momentum with 180+ Companies: DelveInsight.

DelveInsight's 'Antibody-drug Conjugates Competitive Landscape – 2023' report provides comprehensive global coverage of available, marketed, and...

June 27, 2023 | Tuesday | News
Enveric Biosciences Advances EB-373 with Phase 1 Formulation and Manufacturing Initiation.

Enveric to expand existing manufacturing agreement with CDMO partner for enhanced supply of non-GMP and GMP EB-373 drug substance Enveric Biosciences (NAS...

June 27, 2023 | Tuesday | News
Twist Bioscience Publishes Preclinical Data Validating GLP-1R Antagonist Antibody for Congenital Hyperinsulinism Treatment.

-Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

June 27, 2023 | Tuesday | News
IQVIA Launches RIM Smart Labeling for Intelligent Global Label Management.

RIM Smart Labeling is part of IQVIA’s suite of purpose-built regulatory, safety and quality technology solutions and services. Label management is an...

June 27, 2023 | Tuesday | News
AI-Based Health Screening Company iHealthScreen Reaches $150K in Investments

AI-based health screening company iHealthScreen recently announced raising $150,000 in investments on StartEngine. To date, the company has raised $3 milli...

June 27, 2023 | Tuesday | News
FDA Issues First Draft Guidance on Clinical Trials with Psychedelic Drugs

U.S. Food and Drug Administration published a new draft guidance to highlight fundamental considerations to researchers investigating the use of psychedeli...

June 26, 2023 | Monday | Regulatory
Medtronic's MiniMed™ 780G System Shows Promising Data on Meal Dosing and Time in Range

These latest data sets, which evaluated the system across a wide range of users, including historically challenging younger patients, those not meeting gly...

June 26, 2023 | Monday | News
Stanford University and Intonation Research Labs Collaborate to Combat Neuroendocrine Tumors

he goal of the collaboration is to reduce the time and resources it takes to translate a biomedical breakthrough into a clinically and commercially viable ...

June 23, 2023 | Friday | News
Spaulding Clinical Expands Services to Include ADME Clinical Trials

ADME studies are vital components of drug development, providing critical insights into the behavior of drugs within the human body. By measuring the absor...

June 23, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close